Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02692716

Public ClinicalTrials.gov record NCT02692716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 14, 2026, 4:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of the trial is to investigate the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02692716
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
3,183 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 17, 2017 (Actual)
Primary completion
Sep 25, 2018 (Actual)
Completion
Sep 25, 2018 (Actual)
Last update posted
Jul 20, 2022

2017 – 2018

United States locations

U.S. sites
71
U.S. states
24
U.S. cities
61
Facility City State ZIP Site status
Novo Nordisk Investigational Site Little Rock Arkansas 72211 —
Novo Nordisk Investigational Site Searcy Arkansas 72143 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Huntington Beach California 92648 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site La Mesa California 91942 —
Novo Nordisk Investigational Site Lancaster California 93534 —
Novo Nordisk Investigational Site Monterey California 93940 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site San Ramon California 94583 —
Novo Nordisk Investigational Site Ventura California 93003 —
Novo Nordisk Investigational Site Boca Raton Florida 33433 —
Novo Nordisk Investigational Site New Port Richey Florida 34652 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Savannah Georgia 31406 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Springfield Illinois 62702 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Michigan City Indiana 46360 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site Lexington Kentucky 40502 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Monroe Louisiana 71203 —
Novo Nordisk Investigational Site Slidell Louisiana 70461-4231 —
Novo Nordisk Investigational Site Canton Michigan 48187 —
Novo Nordisk Investigational Site Troy Michigan 48098 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Omaha Nebraska 68198 —
Novo Nordisk Investigational Site Las Vegas Nevada 89128 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Albany New York 12203 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site North Massapequa New York 11758-1802 —
Novo Nordisk Investigational Site Westfield New York 14787 —
Novo Nordisk Investigational Site Asheville North Carolina 28803 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Wilmington North Carolina 28401 —
Novo Nordisk Investigational Site Fargo North Dakota 58104 —
Novo Nordisk Investigational Site Cleveland Ohio 44195 —
Novo Nordisk Investigational Site Columbus Ohio 43203 —
Novo Nordisk Investigational Site Maumee Ohio 43537 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114 —
Novo Nordisk Investigational Site Anderson South Carolina 29621 —
Novo Nordisk Investigational Site Moncks Corner South Carolina 29461 —
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Knoxville Tennessee 37938 —
Novo Nordisk Investigational Site Nashville Tennessee 37203 —
Novo Nordisk Investigational Site Nashville Tennessee 37212 —
Novo Nordisk Investigational Site Arlington Texas 76012-4637 —
Novo Nordisk Investigational Site Austin Texas 78705 —
Novo Nordisk Investigational Site Austin Texas 78731 —
Novo Nordisk Investigational Site Austin Texas 78749 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Midland Texas 79707 —
Novo Nordisk Investigational Site Round Rock Texas 78681 —
Novo Nordisk Investigational Site San Antonio Texas 78220 —
Novo Nordisk Investigational Site San Antonio Texas 78228-6205 —
Novo Nordisk Investigational Site Waco Texas 76710 —
Novo Nordisk Investigational Site South Burlington Vermont 05403 —
Novo Nordisk Investigational Site Norfolk Virginia 23510-2015 —
Novo Nordisk Investigational Site Winchester Virginia 22601-3834 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 157 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02692716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2022 · Synced Oct 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02692716 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →